
Patients who filled an opioid prescription following an ophthalmic surgery have higher likelihood of mortality, hospitalization, opioid overdose, and opioid dependence than those who did not fill a prescription, reports a study.
This retrospective, cross-sectional analysis involved patients undergoing ophthalmic surgery, who were identified using administrative claims data from the OptumLabs Data Warehouse. Three cohorts were formed from 1 January 2016 to 30 June 2022.
The first cohort consisted of propensity score-matched patients who had undergone eye surgery and had filled and not filled an opioid prescription. The second one consisted of patients who were considered opioid-naïve and had filled an opioid prescription matched to those who had not filled a prescription. The last cohort involved opioid-naïve patients matched across the following morphine milligram equivalent (MME) groups: ≤40, 41–80, and >80.
A total of 1,577,692 patients underwent ophthalmic surgery, with 312,580 (20 percent) filling an opioid prescription. Filling an opioid prescription after an eye surgery correlated with higher mortality (hazard ratio [HR], 1.28, 95 percent confidence interval [CI], 1.25–1.31; p<0.001), hospitalization (HR, 1.51, 95 percent CI, 1.49–1.53; p<0.001), opioid overdose (HR, 7.31, 95 percent CI, 6.20–8.61; p<0.001), and opioid dependency (HR, 13.05, 95 percent CI, 11.48–14.84; p<0.001) than no opioid prescription.
In addition, higher MME doses of opioids correlated with increased rates of mortality, hospitalization, and abuse or dependence.
“Opioid prescriptions continue to carry significant short- and long-term systemic risks, even after ophthalmic surgery,” the authors said.